Chemotherapy and vitamin D supplement use are determinants of serum 25-hydroxyvitamin D levels during the first six months after colorectal cancer diagnosis
In conclusion, vitamin D supplement use and treatment appear to be important determinants of 25(OH)D3 levels during the first six months after CRC diagnosis, although the difference in 25(OH)D3 levels was minor.ClinicalTrials.gov Identifier: NCT03191110
Source: The Journal of Steroid Biochemistry and Molecular Biology - Category: Biochemistry Source Type: research
More News: Biochemistry | Biology | Calcium | Cancer | Cancer & Oncology | Chemotherapy | Colorectal Cancer | Diets | Molecular Biology | Nutrition | Study | Vitamin D | Vitamins